K+S Aktiengesellschaft SDF.DE
Composite 63/100; the shares have moved about 44% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 16/100 — a strong mark against it.
Balance-sheet strength ranks 86/100 — a strong point in its favour. Valuation ranks 85/100 — a strong point in its favour. Momentum ranks 62/100 — a slight point in its favour.
Growth ranks 16/100 — a strong mark against it. Income ranks 41/100 — a slight mark against it.
What the company does K+S supplies mineral products across agriculture, industry, pharma, and consumer sectors globally. Its portfolio includes potash fertilizers (e.g., KALISOP, PATENTKALI) for crops like grains, citrus, and vegetables, as well as specialty salts and animal nutrition products.
Key financials Profitability is weak: ROE -24.2%, ROA -11.6%, and ROCE -15.8%. Margins are negative (gross -34.6%, operating -13.2%, net -35.2%). Revenue grew 10.0% but EPS surged 359.7% on a low base. Debt/equity is low at 0.15, but interest coverage is negative (-30.94).
Stock health Quality (12.0) and income (10.9) scores are poor, while growth (79.5) is strong. Momentum is mixed: 12m +12.28% but RSI(14) at 64.50 signals overbought conditions. The Piotroski F-Score (5/9) and Altman Z (1.54) suggest moderate financial health risks.
Price vs fair value The stock trades at a **PREMIUM of 67.90%** to our fair-value estimate and a **discount of 10.45%** to the analyst 12-month target. - Trading at a 67.90% premium to fair value (our estimate) despite weak profitability metrics (ROE -24.2%, ROA -11.6%). - Discounted 10.45% to the 12-month target (16.26), implying limited near-term upside per analysts. - Growth (79.5) contrasts with poor quality (12.0) and income (10.9), explaining valuation tension. - High forward P/E (46.73) and negative FCF yield (-51.6%) reflect investor skepticism.
Looking forward Forward P/E (46.73) suggests high expectations are priced in. Growth in revenue (10.0%) and EPS (359.7%) may need to sustain to justify current levels. Valuation percentile (62.0) indicates the stock is fairly valued relative to peers, but profitability remains a key risk. Momentum may hinge on potash demand recovery or cost controls.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.